Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of opioid use disorders: a national clinical practice guideline.

Literature DB >> 29507156

Management of opioid use disorders: a national clinical practice guideline.

Julie Bruneau¹, Keith Ahamad², Marie-Ève Goyer², Ginette Poulin², Peter Selby², Benedikt Fischer², T Cameron Wild², Evan Wood².

Abstract

Mesh：

Substances：

Year: 2018 PMID： 29507156 PMCID： PMC5837873 DOI： 10.1503/cmaj.170958

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

82 in total

1. Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.

Authors: Holger J Schünemann; Lubna A Al-Ansary; Frode Forland; Sonja Kersten; Jorma Komulainen; Ina B Kopp; Fergus Macbeth; Susan M Phillips; Craig Robbins; Philip van der Wees; Amir Qaseem
Journal: Ann Intern Med Date: 2015-10-06 Impact factor: 25.391

2. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

Authors: Robert Hämmig; Wilfried Köhler; Karin Bonorden-Kleij; Bernd Weber; Karin Lebentrau; Toni Berthel; Lucija Babic-Hohnjec; Christian Vollmert; Doris Höpner; Najibulah Gholami; Uwe Verthein; Christian Haasen; Jens Reimer; Christian Ruckes
Journal: J Subst Abuse Treat Date: 2014-06-10

3. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

Authors: Svetlana Puzhko; Élise Roy; Didier Jutras-Aswad; Andreea Adelina Artenie; Emmanuel Fortier; Geng Zang; Julie Bruneau
Journal: Int J Drug Policy Date: 2017-06-27

4. Trends and sex differences in prescription opioid deaths in British Columbia, Canada.

Authors: Emilie J Gladstone; Kate Smolina; Steven G Morgan
Journal: Inj Prev Date: 2015-07-20 Impact factor: 2.399

Review 5. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.

Authors: David E Moody
Journal: Expert Opin Drug Metab Toxicol Date: 2013-03-29 Impact factor: 4.481

Review 6. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors: A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal: Int J Impot Res Date: 2014-07-03 Impact factor: 2.896

Review 7. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors: Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal: Cochrane Database Syst Rev Date: 2009-07-08

Review 8. Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors: Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal: J Subst Abuse Treat Date: 2008-01-14

Review 9. Opioid agonist treatment for pharmaceutical opioid dependent people.

Authors: Suzanne Nielsen; Briony Larance; Louisa Degenhardt; Linda Gowing; Chyanne Kehler; Nicholas Lintzeris
Journal: Cochrane Database Syst Rev Date: 2016-05-09

Review 10. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors: Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal: BMJ Date: 2017-04-26

103 in total

1. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Authors: M Eugenia Socias; Keith Ahamad; Bernard Le Foll; Ron Lim; Julie Bruneau; Benedikt Fischer; T Cameron Wild; Evan Wood; Didier Jutras-Aswad
Journal: Contemp Clin Trials Date: 2018-04-05 Impact factor: 2.226

2. Initiation and Rapid Titration of Methadone in an Acute Care Setting for the Treatment of Opioid Use Disorder: A Case Report.

Authors: Patrick Hemmons; Paxton Bach; Kate Colizza; Seonaid Nolan
Journal: J Addict Med Date: 2019 Sep/Oct Impact factor: 3.702

3.

Authors: Christina Korownyk; Danielle Perry; Joey Ton; Michael R Kolber; Scott Garrison; Betsy Thomas; G Michael Allan; Cheryl Bateman; Raquel de Queiroz; Dorcas Kennedy; Wiplove Lamba; Jazmin Marlinga; Tally Mogus; Tony Nickonchuk; Eli Orrantia; Kim Reich; Nick Wong; Nicolas Dugré; Adrienne J Lindblad
Journal: Can Fam Physician Date: 2019-05 Impact factor: 3.275

4. Managing opioid use disorder in primary care: PEER simplified guideline.

5. Buprenorphine-naloxone.

Authors: Tina Hu; Larry Nijmeh; Adam Pyle
Journal: CMAJ Date: 2018-11-26 Impact factor: 8.262

6. Extended-release naltrexone overlooked in opioid use disorders guideline.

Authors: Launette M Rieb
Journal: CMAJ Date: 2018-07-16 Impact factor: 8.262

7. Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Authors: Didier Jutras-Aswad; Bernard Le Foll; Julie Bruneau; T Cameron Wild; Evan Wood; Benedikt Fischer
Journal: Can J Psychiatry Date: 2018-07-22 Impact factor: 4.356

8. Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada.

Authors: Sarah A Weicker; Kanna Hayashi; Cameron Grant; M-J Milloy; Evan Wood; Thomas Kerr
Journal: Drug Alcohol Depend Date: 2019-10-25 Impact factor: 4.492

9. Comparing Canadian and United States opioid agonist therapy policies.

Authors: Kelsey C Priest; Lauren Gorfinkel; Jan Klimas; Andrea A Jones; Nadia Fairbairn; Dennis McCarty
Journal: Int J Drug Policy Date: 2019-02-11

Review 10. Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.

Authors: Simeon Kimmel; Paxton Bach; Alexander Y Walley
Journal: J Gen Intern Med Date: 2020-05-27 Impact factor: 5.128